Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-5945
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial ; volume:17 ; number:1 ; day:8 ; month:5 ; year:2017 ; pages:1-7 ; date:12.2017
BMC dermatology ; 17, Heft 1 (8.5.2017), 1-7, 12.2017
- Keyword
-
Hautkrankheit
Dermatologie
- Creator
-
Atalay, Selma
- Contributor
-
van den Reek, Juul M. P. A.
van Vugt, Lieke J.
Otero, Marisol E.
van de Kerkhof, Peter C. M.
den Broeder, Alfons A.
Kievit, Wietske
De Jong, Elke M. G. J.
SpringerLink (Online service)
- DOI
-
10.1186/s12895-017-0057-6
- URN
-
urn:nbn:de:1111-20170520248
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Atalay, Selma
- van den Reek, Juul M. P. A.
- van Vugt, Lieke J.
- Otero, Marisol E.
- van de Kerkhof, Peter C. M.
- den Broeder, Alfons A.
- Kievit, Wietske
- De Jong, Elke M. G. J.
- SpringerLink (Online service)
Other Objects (12)
Through the looking glass: understanding non-inferiority
Safe birth in cultural safety in southern Mexico: a pragmatic non-inferiority cluster-randomised controlled trial
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Evidence-based sizing of non-inferiority trials using decision models
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Potential role of “the compensating benefit” in claiming non-inferiority
Phase IV non-inferiority trials and additional claims of benefit
Through the looking glass: understanding non-inferiority
Safe birth in cultural safety in southern Mexico: a pragmatic non-inferiority cluster-randomised controlled trial
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Evidence-based sizing of non-inferiority trials using decision models
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Potential role of “the compensating benefit” in claiming non-inferiority
Phase IV non-inferiority trials and additional claims of benefit
Through the looking glass: understanding non-inferiority
Safe birth in cultural safety in southern Mexico: a pragmatic non-inferiority cluster-randomised controlled trial
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
Evidence-based sizing of non-inferiority trials using decision models
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Potential role of “the compensating benefit” in claiming non-inferiority